Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Celgene receives marketing authorization in Japan for Revlimid

Aug. 20, 2010

SRI International and Taiho furthering development of TAS-108 for breast cancer

Aug. 20, 2010

Combination of first-line bevacizumab and chemotherapy is safe in NSCLC

Aug. 20, 2010

Karus Therapeutics presents new HDAC inhibitors

Aug. 20, 2010

Clavis begins enrollment in phase III trial of elacytarabine in late-stage AML

Aug. 19, 2010

Add-on vandetanib to docetaxel improves progression-free survival in NSCLC

Aug. 19, 2010

Crystal Biopharmaceutical describes new HDAC inhibitors

Aug. 19, 2010

Czech scientists disclose new cell division protein kinase inhibitors

Aug. 19, 2010

European Commission grants midostaurin orphan drug status in mastocytosis

Aug. 18, 2010

Abbott claims new PARP-1 inhibitors

Aug. 18, 2010

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...